Wu Tsai Neurosciences Institute


Showing 1-10 of 59 Results

  • Debra Safer

    Debra Safer

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)

    Current Research and Scholarly InterestsPrimary research interests include the nature and treatment of eating disorders
    (particularly bulimia nervosa and binge eating disorder), the development and treatment of obesity, and the development and treatment of problematic eating patterns in patients following bariatric surgery.

  • Manish Saggar

    Manish Saggar

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)

    Current Research and Scholarly InterestsWe are a computational neuropsychiatry lab dedicated to developing computational methods to better understand brain’s overall dynamical organization in healthy and patient populations. We employ algorithms from a wide range of fields, including Applied Mathematics, Econometrics, Machine Learning, Biophysics, and Network Science.

  • Gregory Lee Sahlem

    Gregory Lee Sahlem

    Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)

    BioDr.Sahlem is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences. He is board-certified in general psychiatry and addictions medicine, as well as fellowship-trained in the research and clinical application of neuromodulation-based treatments including repetitive Transcranial Magnetic Stimulation (rTMS), electroconvulsive therapy (ECT), and vagus nerve stimulation (VNS). He additionally has advanced training in the treatment of mood and sleep disorders. In addition to being an active clinician, Dr.Sahlem is a member of the Stanford Brain Stimulation Lab and directs the Addictions Research Section of the Lab.

    Major areas of study for Dr.Sahlem include: The development of rTMS as a focused treatment for addictive disorders; the development of a novel form of ECT theorized to have reduced cognitive side effects, Focal Electrically Administered Seizure Therapy (FEAST), and; the further development of rTMS for the treatment of mood disorders.

  • Alberto Salleo

    Alberto Salleo

    Hong Seh and Vivian W. M. Lim Professor

    Current Research and Scholarly InterestsNovel materials and processing techniques for large-area and flexible electronic/photonic devices. Polymeric materials for electronics, bioelectronics, and biosensors. Electrochemical devices for neuromorphic computing. Defects and structure/property studies of polymeric semiconductors, nano-structured and amorphous materials in thin films. Advanced characterization techniques for soft matter.

  • Julia Salzman

    Julia Salzman

    Associate Professor of Biomedical Data Science, of Biochemistry and, by courtesy, of Statistics and of Biology

    Current Research and Scholarly Interestsstatistical computational biology focusing on splicing, cancer and microbes

  • Niyatee Samudra, MD

    Niyatee Samudra, MD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Samudra is a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She specializes in the care of patients with memory disorders and epilepsy. She has completed fellowship training in behavioral neurology at the University of California, San Francisco, as well as in epilepsy and clinical neurophysiology at Vanderbilt University Medical Center. Dr. Samudra is board-certified in neurology and in epilepsy.

    Her research interests include clinical trials in memory disorders and epilepsy; early neurophysiological markers of Alzheimer’s disease and related disorders; neuropsychiatric symptoms in neurodegenerative disorders; and the cognitive and neuropsychiatric consequences of epilepsy. She is interested in improving neurologic care for underserved populations.

    Dr. Samudra has published in the Journal of Alzheimer’s Disease; Current Neurology and Neuroscience Reports; Journal of the Neurological Sciences; Seizure; and Epilepsy and Behavior, among others. She is a member of the American Academy of Neurology.

  • Peter L. Santa Maria, MBBS, PhD

    Peter L. Santa Maria, MBBS, PhD

    Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Bioengineering
    On Partial Leave from 08/01/2023 To 07/14/2024

    Current Research and Scholarly InterestsWe study chronic suppurative otitis media, a chronic biofilm infection of the middle ear predominantly involving pseudomonas and staph aureus. We are investigating mechanisms of sensory hearing loss, host microbe interactions and trialling novel therapeutics.

    Our work in tympanic membrane regeneration has entered clinical trials.

    Novel treatments for wound healing in intra oral wounds with potential applications to prevent post tonsillectomy wound healing and oral mucositis.

  • Robert Sapolsky

    Robert Sapolsky

    John A. and Cynthia Fry Gunn Professor, Professor of Biology, of Neurology and of Neurosurgery

    Current Research and Scholarly InterestsNeuron death, stress, gene therapy

  • Ansuman Satpathy

    Ansuman Satpathy

    Assistant Professor of Pathology

    Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.

    We previously developed genome sequencing technologies that enable epigenetic studies in primary human immune cells from patients: 1) 3D enhancer-promoter interaction profiling (Nat Genet, 2017), 2) paired epigenome and T cell receptor (TCR) profiling in single cells (Nat Med, 2018), 3) paired epigenome and CRISPR profiling in single cells (Cell, 2019), and high-throughput single-cell ATAC-seq in droplets (Nature Biotech, 2019). We used these tools to study fundamental principles of the T cell response to cancer immunotherapy (PD-1 blockade) directly in cancer patient samples (Nature Biotech, 2019; Nat Med, 2019).